MedTrace Logo

Study of Evaluation Indexes for Antibody Production in Sera After Immunization

NCT00964769 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2009-08-25

No results posted yet for this study

Summary

The aim of this study is to evaluate analytical methods such as ELISA and OPKA that measure the activity of vaccine-induced pneumococcal antibodies. After validation of ELISA and OPKA, pneumococcal antibodies were measured by ELISA and OPKA in paired samples before and after immunization (pneumococcal PS vaccine) in children, adults and elderly.

Conditions

  • Aged

Interventions

BIOLOGICAL

pneumococcal polysaccharide vaccine

single intramuscular injection of 0.5 ml Pneumo23® (Sanofi-Aventis, Lyon France)

Sponsors & Collaborators

  • Ewha Womans University

    lead OTHER

Principal Investigators

  • Kyung-Hyo Kim, Doctor · Ewha Womans University Dongdaemun Hospital

Study Design

Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2005-05-31
Completion
2005-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00964769 on ClinicalTrials.gov